Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-01 Sale | 2024-04-03 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $42.33 | $2,116,640 | 2,318,055 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $41.01 | $2,050,550 | 2,368,055 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 5:49 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $41.16 | $2,057,890 | 2,418,055 (Direct) | View |
| 2024-02-07 Sale | 2024-02-08 7:14 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 2,506 | $41.54 | $104,110 | 61,960 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $42.24 | $2,111,815 | 2,455,121 (Direct) | View |
| 2023-11-14 Sale | 2023-11-16 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 22,824 | $25.13 | $573,455 | 2,505,121 (Direct) | View |
| 2023-11-07 Sale | 2023-11-09 5:03 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 27,176 | $25.02 | $680,071 | 5,053,286 (Direct) | View |
| 2023-11-02 Sale | 2023-11-06 5:12 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 100,000 | $25.34 | $2,533,697 | 5,168,939 (Direct) | View |
| 2023-09-07 Sale | 2023-09-08 4:35 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $24.07 | $1,203,415 | 2,655,121 (Direct) | View |
| 2023-07-11 Sale | 2023-07-13 5:41 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $30.03 | $1,501,340 | 2,705,121 (Direct) | View |
| 2023-06-01 Sale | 2023-06-05 8:12 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $32.6 | $1,630,070 | 2,755,121 (Direct) | View |
| 2023-05-04 Sale | 2023-05-08 4:24 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $31.47 | $1,573,434 | 2,805,121 (Direct) | View |
| 2023-04-11 Sale | 2023-04-13 4:48 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $25.06 | $1,253,130 | 2,855,121 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $27.12 | $1,355,947 | 5,810,538 (Direct) | View |
| 2023-02-07 Sale | 2023-02-08 8:27 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $33.13 | $1,656,401 | 3,259,925 (Direct) | View |
| 2023-01-05 Sale | 2023-01-06 5:04 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $29.94 | $1,496,871 | 3,005,121 (Direct) | View |
| 2022-12-28 Sale | 2022-12-30 4:10 pm | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 5,758 | $714.11 | $4,111,822 | 1,093 (Direct) | View |
| 2022-12-09 Sale | 2022-12-13 4:44 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $26.67 | $1,333,300 | 3,055,121 (Direct) | View |
| 2022-09-06 Sale | 2022-09-08 4:06 pm | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 6,000 | $581.28 | $3,487,657 | 3,238 (Direct) | View |
| 2021-09-15 Sale | 2021-09-17 4:01 pm | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 11,948 | $658.98 | $7,873,484 | 902 (Direct) | View |
| 2021-08-17 Sale | 2021-08-19 4:04 pm | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 6,000 | $650 | $3,900,000 | 16,080 (Direct) | View |
| 2021-08-13 Sale | 2021-08-16 4:04 pm | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 2,000 | $625 | $1,250,000 | 11,941 (Direct) | View |
| 2020-08-17 Sale | 2020-08-19 3:35 pm | MCKESSON CORP | MCK | COLES N ANTHONY Director | 2,453 | $156.77 | $384,559 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Exercise | 2024-04-03 4:15 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,318,055 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,318,055 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 4:15 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,368,055 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,368,055 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-04 5:49 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,418,055 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-04 5:49 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,418,055 (Direct) | View |
| 2024-02-06 Exercise | 2024-02-08 7:14 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 15,440 | $0 | 61,960 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 4:15 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,455,121 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,455,121 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:11 pm | N/A 2034-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 1,742 | $0 | 3,000 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 4:15 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 22,824 | $0 | 2,505,121 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 22,824 | $3.5 | 2,505,121 (Direct) | View |
| 2023-11-07 Exercise | 2023-11-09 5:03 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 27,176 | $0 | 5,053,286 (Direct) | View |
| 2023-11-07 Exercise | 2023-11-09 5:03 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 27,176 | $3.5 | 5,053,286 (Direct) | View |
| 2023-11-02 Exercise | 2023-11-06 5:12 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 100,000 | $0 | 5,168,939 (Direct) | View |
| 2023-11-02 Exercise | 2023-11-06 5:12 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 100,000 | $3.5 | 5,168,939 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-08 4:35 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,655,121 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-08 4:35 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,655,121 (Direct) | View |
| 2023-07-11 Exercise | 2023-07-13 5:41 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,705,121 (Direct) | View |
| 2023-07-11 Exercise | 2023-07-13 5:41 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,705,121 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-05 8:12 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $0 | 2,755,121 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-05 8:12 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $3.5 | 2,755,121 (Direct) | View |
| 2023-05-04 Exercise | 2023-05-08 4:24 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $0 | 2,805,121 (Direct) | View |
| 2023-05-04 Exercise | 2023-05-08 4:24 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $3.5 | 2,805,121 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 4:48 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $0 | 2,855,121 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 4:48 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $3.5 | 2,855,121 (Direct) | View |
| 2023-03-02 Exercise | 2023-03-06 4:15 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $0 | 5,810,538 (Direct) | View |
| 2023-03-02 Exercise | 2023-03-06 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $3.5 | 5,810,538 (Direct) | View |
| 2023-02-07 Exercise | 2023-02-08 8:27 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $0 | 3,259,925 (Direct) | View |
| 2023-02-07 Exercise | 2023-02-08 8:27 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $3.5 | 3,259,925 (Direct) | View |
| 2023-02-06 Option Award | 2023-02-08 8:27 pm | N/A 2033-02-06 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 304,804 | $0 | 3,259,925 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-06 5:04 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $0 | 3,005,121 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-06 5:04 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $3.5 | 3,005,121 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:15 pm | N/A 2033-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 2,094 | $0 | 3,187 (Direct) | View |
| 2022-12-28 Exercise | 2022-12-30 4:10 pm | N/A 2030-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 5,758 | $0 | 1,093 (Direct) | View |
| 2022-12-28 Exercise | 2022-12-30 4:10 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 2,145 | $374.12 | 1,093 (Direct) | View |
| 2022-12-28 Exercise | 2022-12-30 4:10 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 3,613 | $482.68 | 1,093 (Direct) | View |
| 2022-12-09 Exercise | 2022-12-13 4:44 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $0 | 3,055,121 (Direct) | View |
| 2022-12-09 Exercise | 2022-12-13 4:44 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 50,000 | $3.5 | 3,055,121 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-08 4:06 pm | N/A 2029-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 6,000 | $0 | 3,238 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-08 4:06 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 2,216 | $374.12 | 3,238 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-08 4:06 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 3,784 | $371.4 | 3,238 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:45 pm | N/A 2032-02-09 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson | 425,772 | $0 | 425,772 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:23 pm | N/A 2032-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 2,898 | $0 | 3,800 (Direct) | View |
| 2021-09-15 Exercise | 2021-09-17 4:01 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 6,909 | $380.95 | 902 (Direct) | View |
| 2021-09-15 Exercise | 2021-09-17 4:01 pm | N/A 2027-01-27 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 11,948 | $0 | 902 (Direct) | View |
| 2021-09-15 Exercise | 2021-09-17 4:01 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 5,039 | $345.47 | 902 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 4:04 pm | N/A 2027-01-27 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 6,000 | $0 | 16,080 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 6,000 | $345.47 | 16,080 (Direct) | View |
| 2021-08-13 Exercise | 2021-08-16 4:04 pm | N/A 2027-01-27 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 2,000 | $0 | 11,941 (Direct) | View |
| 2021-08-13 Exercise | 2021-08-16 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 2,000 | $345.47 | 11,941 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 6:05 pm | N/A 2031-03-31 | YUMANITY THERAPEUTICS INC. | YMTX | COLES N ANTHONY Executive Chair | 78,650 | $0 | 78,650 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 6:47 pm | N/A 2031-02-03 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY President and CEO | 732,714 | $0 | 732,714 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 6:36 pm | N/A N/A | YUMANITY THERAPEUTICS INC. | YMTX | COLES N ANTHONY Executive Chair | 1,118 | $0 | 743,677 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 4:11 pm | N/A 2031-01-04 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 3,861 | $0 | 4,515 (Direct) | View |
| 2020-12-22 Option Award | 2020-12-28 7:05 pm | N/A 2028-12-08 | YUMANITY THERAPEUTICS INC. | YMTX | COLES N ANTHONY Executive Chair | 833,175 | $0 | 833,175 (Direct) | View |
| 2020-11-13 Exercise | 2020-11-13 5:57 pm | N/A 2027-01-27 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 11 | $0 | 13,693 (Direct) | View |
| 2020-11-13 Exercise | 2020-11-13 5:57 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 11 | $345.47 | 13,693 (Direct) | View |
| 2020-10-28 Option Award | 2020-10-30 8:13 pm | N/A 2030-10-28 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY President and CEO | 196,335 | $0 | 196,335 (Direct) | View |
Ownership | 2020-10-30 7:45 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY See Remarks | 0 | $0 | 4,136,555 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 6:59 pm | N/A N/A | MCKESSON CORP | MCK | COLES N ANTHONY Director | 1,157 | $0 | 2,453 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 4:01 pm | N/A 2030-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 4,681 | $0 | 5,004 (Direct) | View |
| 2019-07-31 Option Award | 2019-08-01 3:15 pm | N/A N/A | MCKESSON CORP | MCK | COLES N ANTHONY Director | 1,296 | $0 | 1,296 (Direct) | View |